omeros.com (OMER): Qarzning balans kapitallashuviga nisbati
Xomashyo yetkazib beruvchilarni diversifikatsiya qilish orqali Omeros Corporation (OMER) tibbiyot markazlariga barqaror yetkazib berishni ta'minlaydi. Narxlar tendentsiyasi noyob patologiyalarni davolash uchun noyob antitanachalar yaratayotgan kompaniyaning dinamikasini aks ettiradi, bu esa biznesni raqobatchilardan himoya qiladi va AQSh sog'liqni saqlash tizimidagi ta'siri bilan qo'llab-quvvatlanadi. Shu bilan birga, moliyaviy barqarorlik yuqori R&D xarajatlari tufayli cheklangan va joriy ko'rsatkich 0.00 darajasida bo'lib, bu pul oqimlarining tez-tez uchraydigan tebranishlarini ko'rsatadi.
&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_OMER_-_Omeros-Corporation_-_Debt-to-Net-Assets-Ratio "OMER: Omeros Corporation Qarzning balans kapitallashuviga nisbati 04.07.2022 - 29.10.2026 | 👁️GURU.Markets👁️")
omeros.com (OMER) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari
- aksiya narxi va konsensus maqsadli narx:
- birja kapitallashuvi ma'lumotlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning xususiy kapitalga nisbati Omeros Corporation|OMER - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Omeros|OMER - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Omeros Corporation|OMER - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli qarzi Omeros
Kompaniyaning dastlabki tahlili:OMER (Omeros Corp.)
Ushbu ko'rsatkich qarz yuklamasini aksiyalarining bozor qiymati bilan solishtiradi, bu esa investorlarga formulaning maxrajidagi tebranishlar orqali qadrsizlangan aktivlarni aniqlash imkonini beradi. Omeros Corporation (OMER) kompaniyasining qarzning balans qiymatiga nisbatini tahlil qilish juda muhimdir, chunki ushbu biotexnologiya gigantining FDA qarorlariga va moliyalashtirishga bo'lgan bog'liqligi, tijorat sotuvlari yo'qligida balans hisobotini kapital chiqib ketish xavfiga sezgir qiladi.
Muhim raqobatchilar
Biogen Inc. - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar neurocrine.com NBIX|RGC - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati AXSM (Axsome)|ACADIA Pharmaceuticals Inc (ACAD) - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar Xenon Corp (XENE)|Qarzning balans kapitallashuviga nisbati Viking Therapeutics|Balans qiymatiga qarzlar supernus.com SUPN|Qarzning balans kapitallashuviga nisbati Catalyst Pharmaceuticals, Inc. (CPRX)|Qarzning balans qiymatiga nisbati Denali DNLI|Balans kapitallashuviga qarzlar HRMY (Harmony Pharma)|Biohaven Corp (BHVN) - Balans qiymatiga qarzlar|AMLX - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati TRVI (trevitherapeutics.com)|Praxis Precision Medicines, Inc. (PRAX) - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar Anavex (AVXL)|Qarzning balans kapitallashuviga nisbati CeriBell Corp|prothena.com (PRTA) - Sof aktivlarga qarzlar|Qarzning balans qiymatiga nisbati ALEC (Alector, Inc.)|ANNX (annexonbio.com) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar NGNE (Neurogene)|ACIU - Qarzning balans qiymatiga nisbati|VYGR - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar Neumora Corp|Scilex Holding Company (SCLX) - Qarzning balans kapitallashuviga nisbati|tevogen.com - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Alpha Cognition Inc|Cognition Therapeutics Inc. - Qarzlarning balans kapitallashuviga nisbati|Qarzning balans kapitallashuviga nisbati Inhibikase (IKT)|SAVA - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Assertio ASRT|Qarzning sof aktivlarga nisbati COYA|VistaGen Therapeutics Inc - Balans kapitallashuviga qarzlar|OVID - Balans kapitallashuviga qarzlar|ABOS (Acumen Pharma) - Qarzning balans qiymatiga nisbati|CRVO: Qarzning balans kapitaliga nisbati|ATHE (Alterity Therapeutics Ltd.) - Balans kapitallashuviga qarzlar|Clene Nanomedicine (CLNN) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati PepGen Inc. (PEPG)|JUNS - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Relmada RLMD|ANVS: Qarzning balans qiymatiga nisbati|GRCE - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar fireflyneuro.com|anewmeds.com (KLTO) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati NeuroSense Therapeutics Ltd.|RVPH (Reviva Pharmaceuticals Holdings) - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar MetaVia, Inc. MTVA|Qarzning balans kapitallashuviga nisbati NeurAxis, Inc. (NRXS)|HSDT (heliusmedical.com) - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Passage Bio PASG|NEUP: Qarzning balans qiymatiga nisbati|Minerva Neurosciences Corp - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Athira Pharma Corp|ADXN (Addex Therapeutics) - Qarzning balans qiymatiga nisbati|Alzamend Neuro (ALZN) - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Cyclerion Therapeutics Inc.|PTIX: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Pasithea Therapeutics (KTTA)|CRGT - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Avenue Therapeutics ATXI|brainstorm-cell.com (BCLI) - Balans qiymatiga qarzlar|CARA - Qarzning balans kapitallashuviga nisbati|Chromocell Therapeutics Corp (CHRO) - Qarzning balans qiymatiga nisbati|ELYM: Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Intra-Cellular Therapies, Inc. (ITCI)|Qarzning balans kapitallashuviga nisbati Longboard Pharmaceuticals|MRNS: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati NKGen Biotech (NKGN)|NRBO - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Sage Therapeutics, Inc SAGE|Sof aktivlarga qarzlar Synaptogenix, Inc (SNPX)|TRVN: Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati VIGL (Vigil Neuroscience)|WENA: Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Cerevel Therapeutics Inc